Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Gross Profit (2016 - 2025)

Rockwell Medical's Gross Profit history spans 16 years, with the latest figure at $3.9 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 6.8% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $11.7 million, down 33.11%, while the annual FY2025 figure was $11.7 million, 33.11% down from the prior year.
  • Gross Profit reached $3.9 million in Q4 2025 per RMTI's latest filing, up from $2.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $6.2 million in Q3 2024 to a low of -$2.2 million in Q4 2021.
  • Average Gross Profit over 5 years is $2.0 million, with a median of $2.3 million recorded in 2022.
  • Peak YoY movement for Gross Profit: plummeted 679.48% in 2021, then soared 766.03% in 2022.
  • A 5-year view of Gross Profit shows it stood at -$2.2 million in 2021, then surged by 204.89% to $2.3 million in 2022, then grew by 22.65% to $2.9 million in 2023, then increased by 26.52% to $3.6 million in 2024, then rose by 6.8% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Gross Profit are $3.9 million (Q4 2025), $2.3 million (Q3 2025), and $2.5 million (Q2 2025).